AO CSH Mainstream Study on Cervical Spine Degeneration
ConditionCervical Spine Degenerative Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAO Innovation Translation Center
About this trial
Adult patients with cervical degenerative diseases undergoing primary anterior and/or posterior cervical fusion will be prospectively enrolled from participating sites.
Patients will be treated and followed up at the participating sites per local standard of care. Several variables related to the patient characteristics and fusion details will be collected. The mainstream study will not collect follow-up (FU) data.
The duration of this patient cohort is currently planned as open ended.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18 years and older
Undergoing primary surgical treatment for cervical degenerative disease
Ability to provide informed consent according to the IRB/EC defined and approved procedures
Disqualifiers
Age under 18 years
Patients with spinal infection
Patients with spinal tumor
Patients with acute spinal injuries/trauma within 1 year
Trial population
Adult patients with cervical degenerative diseases undergoing primary anterior and/or posterior cervical fusion will be prospectively enrolled from participating sites.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Form a large patient cohort
The primary objective is to form a large prospective multicenter patient cohort with standardized data collection of key patient and treatment characteristics that will drive hypothesis generation in patients with cervical degenerative diseases.
Time frame
BaselineLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: